Population Pharmacokinetics of Dapoxetine in Healthy Chinese Male Subjects.

Dapoxetine is a short‐acting selective serotonin reuptake inhibitor used to treat premature ejaculation. However, its clinical effectiveness is challenged by substantial inter‐individual variability in pharmacokinetics, as both the drug's therapeutic efficacy and the incidence of adverse reactions a...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Clinical Pharmacology Vol. 66; no. 2; pp. 1 - 10
Autores principales: Pu, Libin, Wu, Tong, Bai, Fuqiang, Lu, Haobo, Wang, Yiming, Gao, Yuan, Qiu, Wen
Formato: equations & formulas research tables/charts Journal Article
Publicado: Wiley-Blackwell Feb2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=194233214&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 194233214
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00912700
        5WH
      jtl: Journal of Clinical Pharmacology
      issn: 00912700
      maglogo: Y
    pubinfo:
      dt: Feb2026
      vid: 66
      iid: 2
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        194233214
        188341753
        194233214
        194233214
        10.1002/jcph.70117
        194233214
      ppf: 1
      ppct: 9
      formats:
      tig:
        atl: Population Pharmacokinetics of Dapoxetine in Healthy Chinese Male Subjects.
      aug:
        au:
          Pu, Libin
          Wu, Tong
          Bai, Fuqiang
          Lu, Haobo
          Wang, Yiming
          Gao, Yuan
          Qiu, Wen
        affil: School of Pharmacy, Lanzhou University, Lanzhou Gansu,, China
      sug:
        subj:
          Amines Pharmacokinetics
          Serotonin Uptake Inhibitors Pharmacokinetics
          Men's Health
          Prediction Models
          Sociodemographic Factors
          Pharmacogenetics
          Serotonin Uptake Inhibitors Administration and Dosage
          Human
          Male
          Young Adult
          Funding Source
          China
          Genetic Profile
          Alleles
          Simulations
          Time
          Academic Medical Centers
          Polymorphism, Genetic
          Body Mass Index
          Serotonin Uptake Inhibitors Blood
          Preprocedural Fasting
          Postprandial Period
          Liquid Chromatography-Mass Spectrometry
          Descriptive Statistics
          Data Analysis Software
          Algorithms
          Age Factors
          Body Weight
          Biological Markers Blood
          Aspartate Aminotransferase Blood
          Alanine Aminotransferase Blood
          Bilirubin Blood
          Creatinine Blood
          Blood Urea Nitrogen Evaluation
          Goodness of Fit Chi Square Test
          Confidence Intervals
          Premature Ejaculation Drug Therapy
          Comparative Studies
          Cytochrome P-450 Enzyme System
          Genotype
          Male
      ab: Dapoxetine is a short‐acting selective serotonin reuptake inhibitor used to treat premature ejaculation. However, its clinical effectiveness is challenged by substantial inter‐individual variability in pharmacokinetics, as both the drug's therapeutic efficacy and the incidence of adverse reactions are highly dependent on its exposure. This study aims to develop a population pharmacokinetic model for dapoxetine, to investigate the sources of the variability, and to identify demographic and pharmacogenetic factors that influence drug exposure. The pharmacokinetic data for this analysis were obtained from a bioequivalence study conducted in 39 healthy Chinese male subjects. As part of this study, all volunteers were genotyped for the CYP3A4*1G, CYP3A5*3, CYP2D6*10, and CYP2D6*41 allelic variants. Population pharmacokinetic modeling was performed in Monolix. The final model was then used to simulate and compare the effect of different covariate levels on dapoxetine exposure. A two‐compartment model with first‐order absorption and an absorption lag time best described the pharmacokinetics of dapoxetine. The population parameters for apparent clearance (CL/F), apparent intercompartmental clearance (Q/F), apparent central volume of distribution (Vc/F), apparent peripheral volume of distribution (Vp/F), absorption lag time (Tlag), and absorption rate constant (ka) were 37.8 L/h, 17.2 L/h, 65.6 L, 191.7 L, 0.68 h, and 1.29/h, respectively. CYP2D6*10 and CYP2D6*41 alleles were found to be significant covariates on CL/F. The CYP3A4*1G allele influenced Q/F, while body mass index (BMI) was a significant covariate on Vc/F. Our analysis identified CYP2D6*10 and CYP2D6*41 polymorphisms as the significant factors contributing to inter‐individual variability and influencing drug exposure.
      pubtype: Academic Journal
      doctype:
        equations & formulas
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N